AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 217 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,971 | +31.9% | 101,612 | +0.5% | 0.02% | +53.3% |
| Q4 2023 | $2,252 | -33.9% | 101,114 | -16.0% | 0.02% | -46.4% |
| Q2 2023 | $3,409 | -25.2% | 120,363 | -39.3% | 0.03% | -26.3% |
| Q1 2023 | $4,556 | +1056.3% | 198,366 | +1314.4% | 0.04% | +533.3% |
| Q4 2022 | $394 | -100.0% | 14,025 | -76.7% | 0.01% | -62.5% |
| Q2 2022 | $1,335,000 | -72.5% | 60,238 | -63.8% | 0.02% | -73.8% |
| Q1 2022 | $4,846,000 | +1220.4% | 166,459 | +1390.0% | 0.06% | +1425.0% |
| Q4 2021 | $367,000 | -68.2% | 11,172 | -55.3% | 0.00% | -75.0% |
| Q3 2021 | $1,153,000 | +428.9% | 24,978 | +530.4% | 0.02% | +700.0% |
| Q2 2021 | $218,000 | -93.9% | 3,962 | -94.2% | 0.00% | -96.2% |
| Q1 2021 | $3,546,000 | +14.3% | 68,673 | -4.1% | 0.05% | +73.3% |
| Q4 2020 | $3,102,000 | +197.7% | 71,601 | +140.5% | 0.03% | +42.9% |
| Q3 2020 | $1,042,000 | -67.5% | 29,772 | -50.3% | 0.02% | -74.7% |
| Q2 2020 | $3,204,000 | +276.5% | 59,908 | +374.7% | 0.08% | +31.7% |
| Q1 2019 | $851,000 | – | 12,621 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 354,650 | $18,314,000 | 7.19% |
| Casdin Capital, LLC | 2,165,000 | $111,801,000 | 3.33% |
| Rock Springs Capital Management LP | 2,543,600 | $131,352,000 | 2.87% |
| HealthCor Management, L.P. | 1,532,960 | $79,162,000 | 2.80% |
| Bellevue Group AG | 4,537,092 | $234,295,000 | 2.48% |
| Woodline Partners LP | 824,097 | $42,556,000 | 0.94% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,081,347 | $55,841,000 | 0.83% |
| Integral Health Asset Management, LLC | 43,000 | $2,221,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,119,566 | $57,814,000 | 0.43% |
| Virtus ETF Advisers LLC | 18,328 | $946,000 | 0.40% |